Sharing views on Intuitive Surgical (ISRG), Wall Street analysts label it a worthwhile investment. Objective Capital Management LLC invested $467,000 into the company. Despite underperforming the market recently, ISRG has reported double-digit growth for Q3 in both revenue and earnings. Tompkins Financial Corp and Kornitzer Capital Management Inc. KS sold their shares. Brokers consider ISRG to be a good investment, with its financial growth fueled by the AI-Driven Da Vinci Systems.
The Q3 2024 earnings call highlighted strong revenue and procedure growth. UBS included ISRG amongst their top tech-based disruptive stocks for 2030. The company's stock performance has reflected its robust financial health. Even though ISRG is experiencing falls and fluctuations in the market, analysts predict a rise. The company's Q3 earnings reports have beaten estimates. Intuitive Surgical's popularity has grown due to its development in robotic surgeries and strong Q3 results. It has gained 40.5% Year to Date (YTD). Despite being 40.5% up YTD, there are questions regarding valuation. Major institutional investors have acquired and offloaded shares recently.
Intuitive Surgical ISRG News Analytics from Mon, 10 Jun 2024 07:00:00 GMT to Sat, 09 Nov 2024 15:27:18 GMT - Rating 7 - Innovation 8 - Rumor -1
